SE446740B - Forfarande for framstellning av muramyldipeptidderivat - Google Patents

Forfarande for framstellning av muramyldipeptidderivat

Info

Publication number
SE446740B
SE446740B SE7707276A SE7707276A SE446740B SE 446740 B SE446740 B SE 446740B SE 7707276 A SE7707276 A SE 7707276A SE 7707276 A SE7707276 A SE 7707276A SE 446740 B SE446740 B SE 446740B
Authority
SE
Sweden
Prior art keywords
preparing
procedure
muramyldipeptide derivatives
muramyldipeptide
derivatives
Prior art date
Application number
SE7707276A
Other languages
English (en)
Swedish (sv)
Other versions
SE7707276L (sv
Inventor
Y Yamamura
T Shiba
I Azuma
S Kusumoto
T Hirayama
T Kusama
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7407276A external-priority patent/JPS5914038B2/ja
Priority claimed from JP51150328A external-priority patent/JPS6033119B2/ja
Priority claimed from JP1112277A external-priority patent/JPS5398922A/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of SE7707276L publication Critical patent/SE7707276L/
Publication of SE446740B publication Critical patent/SE446740B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE7707276A 1976-06-23 1977-06-22 Forfarande for framstellning av muramyldipeptidderivat SE446740B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7407276A JPS5914038B2 (ja) 1976-06-23 1976-06-23 新規ムラミルジペプチド誘導体
JP51150328A JPS6033119B2 (ja) 1976-12-16 1976-12-16 新規ムラミルジペプチド誘導体
JP1112277A JPS5398922A (en) 1977-02-03 1977-02-03 Novel melamyldipeptide derivative

Publications (2)

Publication Number Publication Date
SE7707276L SE7707276L (sv) 1978-02-10
SE446740B true SE446740B (sv) 1986-10-06

Family

ID=27279285

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7707276A SE446740B (sv) 1976-06-23 1977-06-22 Forfarande for framstellning av muramyldipeptidderivat

Country Status (9)

Country Link
US (1) US4101536A (en:Method)
CA (1) CA1105005A (en:Method)
CH (1) CH624124A5 (en:Method)
DE (1) DE2728324A1 (en:Method)
FR (1) FR2375249A1 (en:Method)
GB (1) GB1563561A (en:Method)
NL (1) NL171063C (en:Method)
SE (1) SE446740B (en:Method)
SU (1) SU793384A3 (en:Method)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
JPS5543030A (en) * 1978-09-21 1980-03-26 Dai Ichi Seiyaku Co Ltd Prophylactic and remedy for microbial infection disease
DE2965017D1 (en) * 1978-12-22 1983-04-14 Anvar New compounds associating peptidyl or aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
US4391800A (en) * 1979-04-27 1983-07-05 Merck & Co., Inc. Immunologically active peptidyl disaccharides and methods of preparation
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4340588A (en) * 1980-03-28 1982-07-20 Research Corporation Brucellosis vaccine for cattle containing mycolate esters of trehalose
US4310514A (en) * 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
US4315913A (en) * 1980-06-09 1982-02-16 Merck & Co. Inc. Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
GR78246B (en:Method) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
DE3840538A1 (de) * 1988-12-01 1990-06-07 Helopharm Petrik Co Kg Peptidoglucan-dimere, verfahren zu ihrer herstellung und ihre verwendung als immunmodulatoren
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
EP1670508B1 (en) 2003-02-28 2012-10-24 Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
WO2006112869A2 (en) * 2004-07-19 2006-10-26 Baylor College Of Medicine Modulation of cytokine signaling regulators and applications for immunotherapy
KR101203401B1 (ko) * 2005-06-08 2012-11-22 이쉥 바이오파마(싱가포르)피티이 리미티드 폴리이노신산-폴리시티딜산-기초 보조제
US7868159B2 (en) * 2005-06-23 2011-01-11 Baylor College Of Medicine Modulation of negative immune regulators and applications for immunotherapy
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
EP2136832B1 (en) 2007-03-26 2015-09-02 General Regeneratives Limited Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies
WO2009082593A2 (en) * 2007-11-30 2009-07-02 Baylor College Of Medicine Dendritic cell vaccine compositions and uses of same
US9808504B2 (en) 2009-09-22 2017-11-07 Yale University Immunogenic epitopes as targets for universal cancer vaccines
CA2846486C (en) 2011-07-12 2019-08-20 Philadelphia Health & Education Corporation Novel clostridium difficile dna vaccine
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations
WO2025096754A1 (en) 2023-10-31 2025-05-08 Musc Foundation For Research Development The use of enolase inhibitor pomhex for treatment of fibrosis

Also Published As

Publication number Publication date
CA1105005A (en) 1981-07-14
CH624124A5 (en:Method) 1981-07-15
FR2375249B1 (en:Method) 1980-04-11
NL171063B (nl) 1982-09-01
DE2728324C2 (en:Method) 1988-07-07
FR2375249A1 (fr) 1978-07-21
DE2728324A1 (de) 1978-01-12
NL7706948A (nl) 1977-12-28
US4101536A (en) 1978-07-18
SE7707276L (sv) 1978-02-10
SU793384A3 (ru) 1980-12-30
NL171063C (nl) 1983-02-01
GB1563561A (en) 1980-03-26

Similar Documents

Publication Publication Date Title
SE446740B (sv) Forfarande for framstellning av muramyldipeptidderivat
SE440791B (sv) Forfarande for upparbetning av lignitkol
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
SE7704949L (sv) Forfarande for framstellning av emulsioner
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE442195B (sv) Forfarande for framstellning av etrar
IT1076788B (it) Procedimento per preparare organopolisilossani
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
SE425490B (sv) Forfarande for framstellning av bis-penicillanoyloxi-alkaner
SE431542B (sv) Forfarande for framstellning av 3-fenoxipyridin-monosulfat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7707276-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7707276-7

Format of ref document f/p: F